Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy
- 1 May 2016
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 15 (5) , 447-450
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicineArthritis Care & Research, 2012
- Obesity, waist circumference, weight change and the risk of psoriasis in US womenJournal of the European Academy of Dermatology and Venereology, 2012
- Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapyScandinavian Journal of Rheumatology, 2012
- Obesity and risk of incident psoriatic arthritis in US womenAnnals of the Rheumatic Diseases, 2012
- Association between body mass index and anti–citrullinated protein antibody–positive and anti–citrullinated protein antibody–negative rheumatoid arthritis: Results from a population‐based case–control studyArthritis Care & Research, 2012
- Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritisArthritis Care & Research, 2012
- Body mass index and clinical response to infliximab in rheumatoid arthritisArthritis & Rheumatism, 2010
- Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapyDermatologic Therapy, 2010
- A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2008
- Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass indexArthritis & Rheumatism, 2007